Bio-Techne Corp (TECH) Financials

TECH Assets vs Liabilities

DateAssetsLiabilities
2023-12-31 2.7 billion 767.2 million
2023-09-30 2.8 billion 757.6 million
2023-06-30 2.6 billion 672.2 million
2023-03-31 2.6 billion 710.0 million

TECH Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-12-31 68.3 million 12.8 million
2023-09-30 45.8 million 10.1 million
2023-06-30 72.6 million -2.1 million
2023-03-31 38.8 million 10.1 million

TECH Net Income

Graph available only for supporters. Become a supporter to see it.
DateNet Income
2023-12-31 27.5 million
2023-09-30 51.0 million
2023-06-30 75.5 million
2023-03-31 70.2 million

TECH Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-12-31 135.7 million - 108.7 million
2023-09-30 148.7 million - 109.5 million
2023-06-30 204.3 million 350.0 million 105.0 million
2023-03-31 157.2 million 370.0 million 104.0 million

TECH Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-12-31 160.1 million
2023-09-30 161.9 million
2023-06-30 161.9 million
2023-03-31 161.6 million

TECH Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-12-31 14.9 million 22.9 million 115.7 million -
2023-09-30 13.6 million 24.0 million 105.3 million -
2023-06-30 10.8 million 23.4 million 86.8 million -
2023-03-31 11.7 million 22.7 million 99.2 million -

TECH Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-12-31 272.6 million 96.0 million
2023-09-30 276.9 million 91.7 million
2023-06-30 301.3 million 96.6 million
2023-03-31 294.1 million 92.0 million

TECH

Price: $64.06

52 week price:
51.79
89.91

Dividend Yield: 0.00%

5-year range yield:
0.00%
6.02%

Forward Dividend Yield: 0.50%

Payout Ratio: 23.02%

Payout Ratio Range:
12.55%
68.80%

Dividend Per Share: 0.32 USD

Earnings Per Share: 1.39 USD

P/E Ratio: 47.47

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 837800

Ebitda: 39.7 million

Market Capitalization: 10.5 billion

Average Dividend Frequency: 4

Years Paying Dividends: 17

DGR3: 30.00%

DGR5: 20.00%

DGR10: 11.00%

Links: